LADENBURG THALMANN FINANCIAL SERVICES INC. - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 75 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 1.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2019$38,000
-58.7%
9,795
-6.0%
0.00%
-100.0%
Q3 2019$92,000
+9100.0%
10,420
+38492.6%
0.00%
Q2 2018$1,0000.0%270.0%0.00%
Q1 2018$1,0000.0%270.0%0.00%
Q4 2017$1,000270.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,440,419$102,697,00037.12%
RTW INVESTMENTS, LP 1,028,929$30,714,0008.08%
Consonance Capital Management LP 1,420,742$42,409,0004.44%
Perceptive Advisors 2,139,274$63,857,0003.64%
Broadfin Capital, LLC 782,887$23,369,0002.83%
Crawford Lake Capital Management, LLC 171,373$5,115,0002.03%
Crawford Lake Capital Management, LLC 162,600$4,380,0001.74%
ISZO CAPITAL MANAGEMENT LP 30,967$924,0001.61%
FT Options LLC 33,141$989,0001.30%
Monashee Investment Management LLC 100,000$2,985,0001.20%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders